- Record: found
- Abstract: not found
- Article: not found
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
Shirish Gadgeel, Leena Gandhi, Gregory J. Riely, Alberto Chiappori, Howard West, Michele C Azada, Peter Morcos, Ruey-Min Lee, Linta Garcia, Li Yu, Frédéric Boisserie, Laura Di Laurenzio, Sophie Golding, Jotaro Sato, Shumpei Yokoyama, Tomohiro Tanaka, Sai-Hong Ignatius Ou
2014-09-01
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Journal
10.1016/S1470-2045(14)70362-6
https://www.elsevier.com/tdm/userlicense/1.0/